These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3782805)

  • 1. Antibodies to thymopoietin following implantation of paper disks derivatized with synthetic Cys-thymopoietin.
    Viamontes GI; Audhya T; Goldstein G
    J Immunol Methods; 1986 Nov; 94(1-2):13-7. PubMed ID: 3782805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of thymopoietin with an antiserum to synthetic Cys-thymopoietin28-39.
    Viamontes GI; Audhya T; Goldstein G
    Cell Immunol; 1986 Jul; 100(2):305-13. PubMed ID: 2428508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structural similarity and functional activity of molecular fragments of staphylococcal enterotoxin B and thymopoietin II].
    Vegner RE; Rituma IR; Chipens GI; Duplishcheva AP; Mysiakin EB
    Bioorg Khim; 1987 Jan; 13(1):122-4. PubMed ID: 3566816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements for the biological activity of thymopentin analogs.
    Heavner GA; Audhya T; Kroon D; Goldstein G
    Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopoietin to thymopentin: experimental studies.
    Goldstein G; Audhya TK
    Surv Immunol Res; 1985; 4 Suppl 1():1-10. PubMed ID: 2994196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity of aqueous extracts of rat and mouse tissue with anti-thymosin alpha 1, anti-bovine thymopoietin and anti-thymulin antibodies. Studies using immunoblotting.
    Monier JC; Auger C; Corvee N; Stahli C; Fabien N
    Thymus; 1988; 11(3):173-83. PubMed ID: 3363629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro differentiation of two surface markers for immature T cells by the synthetic pentapeptide, thymopoietin.
    Nash L; Good RA; Hatzfeld A; Goldstein G; Incefy GS
    J Immunol; 1981 Jan; 126(1):150-3. PubMed ID: 6969740
    [No Abstract]   [Full Text] [Related]  

  • 8. Cooperativity of thymopoietin 32-36 (the active site) and thymopoietin 38-45 in receptor binding.
    Audhya T; Heavner GA; Kroon DJ; Goldstein G
    Regul Pept; 1984 Oct; 9(3):155-64. PubMed ID: 6098937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of new thymopoietin derivatives on the immune response of inbred mice.
    Rajnavölgyi E; Kulics J; Szilágyvári M; Kisfaludy L; Nyéki O; Schön I; Gergely J
    Int J Immunopharmacol; 1986; 8(2):167-77. PubMed ID: 3519478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.
    Goldstein G; Scheid MP; Boyse EA; Schlesinger DH; Van Wauwe J
    Science; 1979 Jun; 204(4399):1309-10. PubMed ID: 451537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.
    Ochoa EL; Medrano S; de Carlin MC; Dilonardo AM
    Cell Mol Neurobiol; 1988 Sep; 8(3):325-31. PubMed ID: 3066488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoassay for bovine serum thymopoietin: discrimination from splenin by monoclonal antibodies.
    Fuccello A; Audhya T; Talle MA; Goldstein G
    Arch Biochem Biophys; 1984 Jan; 228(1):292-8. PubMed ID: 6364989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and complete amino acid sequence of human thymopoietin and splenin.
    Audhya T; Schlesinger DH; Goldstein G
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3545-9. PubMed ID: 3473468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary relationship of thymopoietin to immunoglobulins and cellular recognition molecules.
    Hahn GS; Hamburger RN
    J Immunol; 1981 Feb; 126(2):459-62. PubMed ID: 7005338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulation by thymopoietin.
    Goldstein G; Lau CY
    J Supramol Struct; 1980; 14(3):397-403. PubMed ID: 6971374
    [No Abstract]   [Full Text] [Related]  

  • 16. Short in vitro half-life of thymopoietin32--36 pentapeptide in human plasma.
    Tischio JP; Patrick JE; Weintraub HS; Chasin M; Goldstein G
    Int J Pept Protein Res; 1979; 14(5):479-84. PubMed ID: 395119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines.
    Heavner GA; Audhya T; Goldstein G
    Regul Pept; 1990 Feb; 27(2):257-62. PubMed ID: 2158125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymopentin: stability considerations and potency by various routes of administration.
    Audhya TK; Goldstein G
    Surv Immunol Res; 1985; 4 Suppl 1():17-23. PubMed ID: 3898289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulating peptides II. In vitro effects of TP5 analogs on E-rosette formation and cell division.
    Denes L; Szende B; Ember J; Major J; Szporny L; Hajos G; Nyeki O; Schon I; Lapis K; Kisfaludy L
    Immunopharmacol Immunotoxicol; 1987; 9(1):1-18. PubMed ID: 3330094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin.
    Morel E; Vernet-der Garabedian B; Raimond F; Audhya TK; Goldstein G; Bach JF
    Eur J Immunol; 1987 Aug; 17(8):1109-13. PubMed ID: 3622601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.